Compare WST & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | EXPD |
|---|---|---|
| Founded | 1923 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6B | 21.0B |
| IPO Year | 2004 | 1995 |
| Metric | WST | EXPD |
|---|---|---|
| Price | $331.30 | $171.48 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 11 |
| Target Price | ★ $325.86 | $133.00 |
| AVG Volume (30 Days) | 726.5K | ★ 1.2M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | 0.30% | ★ 1.03% |
| EPS Growth | 1.49 | ★ 4.02 |
| EPS | ★ 4.07 | 1.71 |
| Revenue | $2,886,900,000.00 | ★ $6,920,948,000.00 |
| Revenue This Year | $6.76 | $2.71 |
| Revenue Next Year | $6.22 | $3.74 |
| P/E Ratio | ★ $81.39 | $100.20 |
| Revenue Growth | 1.95 | ★ 13.49 |
| 52 Week Low | $223.83 | $110.48 |
| 52 Week High | $386.00 | $183.52 |
| Indicator | WST | EXPD |
|---|---|---|
| Relative Strength Index (RSI) | 38.40 | 50.16 |
| Support Level | $321.94 | $157.54 |
| Resistance Level | $336.82 | $183.52 |
| Average True Range (ATR) | 11.14 | 3.65 |
| MACD | -4.53 | -0.61 |
| Stochastic Oscillator | 8.30 | 39.09 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2025, Expeditors derived 36% of consolidated gross revenue from airfreight, 25% from ocean freight, and 39% from customs brokerage and other services.